What is Novanta's market cap?

Novanta (NOVT) has a market capitalization of $5.0B and trades on NASDAQ.

What is Novanta's revenue and profitability?

Novanta generated $1.0B in trailing twelve-month revenue with net income of $53.7M, representing a net margin of 5.3%. Gross margin stands at 44.2%, with free cash flow of $68.5M. These figures are based on the Q1 2026 filing.

Who are Novanta's competitors?

Novanta's key competitors include Stryker Corporation, Intuitive Surgical, Coherent Corp., and others. These companies compete in similar markets and product categories.

What subsidiaries does Novanta have?

Novanta's subsidiaries include Keonn Technologies, S.L., Motion Solutions Parent Corp., ATI Industrial Automation, Inc., and others.

Where is Novanta headquartered?

Novanta is headquartered in United States of America and employs approximately 2,900 people. It has been publicly traded since 1999.

Novanta

NOVT

Novanta Inc. is a leading global supplier of core technology solutions specializing in precision medicine, robotics, and advanced industrial automation.

Market cap

$5.01B+13.1%

Revenue$1.0B+5.6%

Net income$53.7M-23.9%

Free cash flow$68.5M-51.9%

EPS (diluted)$1.39-28.7%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q2 2026 report

May 11, 2026

Revenue$257.7MBeat by $4.3M EPS$0.81Beat by $0.03

Read the full report

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$262.3M

EPS estimate$0.83

Financials

Q1 2026

Income statement

See full

Revenue$257.7M+10.4%

Gross profit$113.6M+8.8%

Operating income$27.5M-15.1%

Net income$21.1M-0.5%

EPS (diluted)$0.51-13.6%

Balance sheet

See full

Cash & equivalents$388.8M+267%

Total debt$291.3M-34.2%

Total equity$1.3B+70.3%

Total assets$1.8B+29.9%

Cash flow

See full

Operating cash flow$51.6M+62.9%

CapEx$4.1M-3.4%

Free cash flow$47.5M+73.2%

Valuation & ratios

Valuation

See full

Market cap$5.01B+13.1%

Enterprise value$4.92B+0.6%

P/E93.3×+20.3×

P/S5×+0.3×

Profitability

See full

Gross margin44.2%-0.5pp

Operating margin8.9%-3.5pp

Net margin5.3%-2.1pp

FCF margin6.8%-8.1pp

Returns & leverage

See full

Return on equity5.2%-4.6pp

Debt / equity0.2×-0.4×

Current ratio3.6×+1.0×

Segments

By segment

See full

Automation Enabling Technologies$131.2M+6.6%

Medical Solutions$126.5M+14.8%

Robotics And Automation$84.2M+7.1%

Competitors

By market cap

Stryker$129.09B-15.7%

Intuitive Surgical$127.84B-27.8%

Coherent$53.1B+227%

Nordson$16.6B+33.7%

Globus Medical$10.6B+44.5%

Novanta$5.0B+11.9%

Allient Inc.$1.5B+118%

Nortech Systems$42.0M+77.1%

By revenue growth

Globus Medical+23.5%

Intuitive Surgical+20.7%

Novanta+5.6%

By net margin

Intuitive Surgical28.45%-0.1pp

Globus Medical18.92%+11.5pp

Nordson18.19%+1.7pp

Stryker13.21%+0.9pp

Novanta5.35%-2.1pp

Allient Inc.4.25%+2.3pp

Coherent1.73%+7.6pp

Profile

Novanta Inc. is a leading global supplier of core technology solutions specializing in precision medicine, robotics, and advanced industrial automation. The company engineers proprietary components and sub-systems for original equipment manufacturers (OEMs) in the medical and advanced industrial markets. Its value proposition centers on solving complex technical challenges through deep expertise in laser beam steering, precision motion, and medical-grade surgical technologies.

Competitive position

Novanta maintains a leading position by integrating proprietary technology into long life-cycle OEM platforms, creating significant barriers to entry once designed into customer systems.

GeographiesUnited States, Europe, Asia

Customer segmentsMedical Device OEMs, Advanced Industrial OEMs, Life Science Organizations

Business modelB2B, OEM Manufacturing, Proprietary Hardware

SuppliersRaw material suppliers, Electronic component manufacturers, Third-party subassembly manufacturers

CustomersMedical equipment OEMs, Industrial robotics integrators, Semiconductor manufacturing equipment providers, Hospital and healthcare providers

CountryUnited States of America

Listed1999

Employees2.9K

CEOMatthijs Glastra

SectorTechnology

IndustryHardware, Equipment & Parts

Websitenovanta.com

FilingsSEC EDGAR

Ask your AI about Novanta.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novanta's market cap?: Novanta (NOVT) has a market capitalization of $5.0B and trades on NASDAQ.
What is Novanta's revenue and profitability?: Novanta generated $1.0B in trailing twelve-month revenue with net income of $53.7M, representing a net margin of 5.3%. Gross margin stands at 44.2%, with free cash flow of $68.5M. These figures are based on the Q1 2026 filing.
Who are Novanta's competitors?: Novanta's key competitors include Stryker Corporation, Intuitive Surgical, Coherent Corp., and others. These companies compete in similar markets and product categories.
What subsidiaries does Novanta have?: Novanta's subsidiaries include Keonn Technologies, S.L., Motion Solutions Parent Corp., ATI Industrial Automation, Inc., and others.
Where is Novanta headquartered?: Novanta is headquartered in United States of America and employs approximately 2,900 people. It has been publicly traded since 1999.